This Purple Innovation Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Avi Kapoor 6 months ago
NewsDowngradesPre-Market OutlookMarketsAnalyst RatingsTrading Ideas
Wall Street analysts changed outlook on top names. See all rating changes on analyst ratings page. PRPL, OPK, BF.B, MELI, RPD stocks downgraded.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Keybanc analyst Bradley B. Thomas downgraded Purple Innovation Inc (NASDAQ:PRPL) from Overweight to Sector Weight. Purple Innovation shares closed at $0.53 on Tuesday. See how other analysts view this stock.
- Barrington Research analyst Michael Petusky downgraded OPKO Health Inc (NASDAQ:OPK) from Outperform to Market Perform. OPKO Health shares closed at $1.21 on Tuesday. See how other analysts view this stock.
- JP Morgan analyst Drew Levine downgraded Brown-Forman Corp (NYSE:BF.B) from Neutral to Underweight and cut the price target from $27 to $23. Brown-Forman shares closed at $27.73 on Tuesday. See how other analysts view this stock.
- UBS analyst Kaio Prato downgraded MercadoLibre Inc (NASDAQ:MELI) from Buy to Neutral and cut the price target from $2,700 to $2,050. MercadoLibre shares closed at $1,791.99 on Tuesday. See how other analysts view this stock.
- William Blair analyst Jonathan Ho downgraded Rapid7, Inc. (NASDAQ:RPD) from Outperform to Market Perform. Rapid7 shares closed at $5.82 on Tuesday. See how other analysts view this stock.
Considering buying PRPL stock? Here’s what analysts think:

Photo via Shutterstock